C19H26ClN5O4
423.9 g/mol
APIWarning
Terazosin HCl
CAS63074-08-8EC613-138-7
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Terazosin HCl is a salt form of terazosin, a compound used as an active pharmaceutical ingredient. It is primarily supplied to pharmaceutical manufacturers for use in drug product development and production.
active pharmaceutical ingredient for pharmaceutical manufacturingraw material for drug formulation development
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 63074-08-8
Related Compounds
StrongSame Parent
Terazosin
CAS63590-64-7
pharmaceutical raw material
StrongSame Parent
Terazosin hydrochloride dihydrate
CAS70024-40-7
pharmaceutical raw material
ReferenceSame Category
1|A-Calcidol
CAS63181-13-5
pharmaceutical raw material
ReferenceSame Category
D-threonine zwitterion
CAS632-20-2
pharmaceutical raw material
ReferenceSame Category
Calcifediol monohydrate
CAS63283-36-3
pharmaceutical raw material
ReferenceSame Category
Berberine hydrochloride
CAS633-65-8
pharmaceutical raw material
Safety Reference
Warning
H302Harmful if swallowed
H319Causes serious eye irritation
H361Suspected of damaging fertility or the unborn child
Identifiers
IUPAC Name
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;hydrochloride
InChIKey
IWSWDOUXSCRCKW-UHFFFAOYSA-N
SMILES
COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.Cl
Synonyms (22)
- ABBOTT-45975 ANHYDROUS
- Hytrin
- Prazosin Tetrahydro Impurity
- Terazosin (hydrochloride)
- Terazosin HCl
- Tetrazosin hydrochloride
- Vasocard
- Zayasel